Literature DB >> 21597025

Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function.

Darren A Yuen1, Michael A Kuliszewski, Christine Liao, Dmitriy Rudenko, Howard Leong-Poi, Christopher T Chan.   

Abstract

BACKGROUND AND OBJECTIVES: Angiogenesis is a key response to tissue ischemia that may be impaired by uremia. Although early-outgrowth endothelial progenitor-like cells promote angiogenesis in the setting of normal renal function, cells from uremic patients are dysfunctional. When compared with conventional hemodialysis, it was hypothesized that nocturnal hemodialysis would improve the in vivo angiogenic activity of these cells in a well described model of ischemic vascular disease. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: Early-outgrowth endothelial progenitor-like cells were cultured from healthy controls (n = 5) and age- and gender-matched conventional hemodialysis (12 h/wk, n = 10) and nocturnal hemodialysis (30 to 50 h/wk, n = 9) patients. Cells (5 × 10(5)) or saline were injected into the ischemic hindlimb of athymic nude rats 1 day after left common iliac artery ligation.
RESULTS: Although conventional dialysis cell injection had no effect versus saline, nocturnal hemodialysis and healthy control cell injection significantly improved ischemic hindlimb perfusion and capillary density. Nocturnal hemodialysis cell injection was also associated with significant increases in endogenous angiopoietin 1 expression in the ischemic hindlimb compared with saline and conventional dialysis cell injection.
CONCLUSIONS: In contrast to a conventional dialytic regimen, nocturnal hemodialysis is associated with a significantly improved ability of early-outgrowth endothelial progenitor-like cells to promote angiogenesis and thus restore perfusion in a model of ischemic vascular disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597025      PMCID: PMC3109931          DOI: 10.2215/CJN.10911210

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  44 in total

1.  Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.

Authors:  Daniel P Sieveking; Andrew Buckle; David S Celermajer; Martin K C Ng
Journal:  J Am Coll Cardiol       Date:  2008-02-12       Impact factor: 24.094

2.  Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.

Authors:  Darren A Yuen; Kim A Connelly; Andrew Advani; Christine Liao; Michael A Kuliszewski; Judy Trogadis; Kerri Thai; Suzanne L Advani; Yuan Zhang; Darren J Kelly; Howard Leong-Poi; Armand Keating; Philip A Marsden; Duncan J Stewart; Richard E Gilbert
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

3.  Percent reduction in blood urea concentration during hemodialysis (PRU). A simple and accurate method to estimate Kt/V urea.

Authors:  K K Jindal; A Manuel; M B Goldstein
Journal:  ASAIO Trans       Date:  1987 Jul-Sep

4.  Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization.

Authors:  Jaimy Saif; Theresa M Schwarz; David Y S Chau; James Henstock; Paramjit Sami; Simon F Leicht; Patrick C Hermann; Sonia Alcala; Francisca Mulero; Kevin M Shakesheff; Christopher Heeschen; Alexandra Aicher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-05       Impact factor: 8.311

5.  Relationship between apparent (single-pool) and true (double-pool) urea distribution volume.

Authors:  J T Daugirdas; T Greene; T A Depner; F A Gotch; R A Star
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

6.  Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension.

Authors:  Mark L Ormiston; Yupu Deng; Duncan J Stewart; David W Courtman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-07       Impact factor: 6.914

7.  Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.

Authors:  Bruce F Culleton; Michael Walsh; Scott W Klarenbach; Garth Mortis; Narine Scott-Douglas; Robert R Quinn; Marcello Tonelli; Sarah Donnelly; Matthias G Friedrich; Andreas Kumar; Houman Mahallati; Brenda R Hemmelgarn; Braden J Manns
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

Review 8.  Assessment and significance of arterial stiffness in patients with chronic kidney disease.

Authors:  Alain P Guérin; Bruno Pannier; Fabien Métivier; Sylvain J Marchais; Gérard M London
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-11       Impact factor: 2.894

9.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

10.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

Authors:  C Kalka; H Masuda; T Takahashi; W M Kalka-Moll; M Silver; M Kearney; T Li; J M Isner; T Asahara
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  9 in total

1.  Temporal Trends and Factors Associated with Home Hemodialysis Technique Survival in Canada.

Authors:  Jeffrey Perl; Yingbo Na; Karthik K Tennankore; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 8.237

2.  Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.

Authors:  Paweena Susantitaphong; Ioannis Koulouridis; Ethan M Balk; Nicolaos E Madias; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-02-25       Impact factor: 8.860

3.  Reduction of carbamylated albumin by extended hemodialysis.

Authors:  Jeffrey Perl; Sahir Kalim; Ron Wald; Marc B Goldstein; Andrew T Yan; Nazanin Noori; Mercedeh Kiaii; Julia Wenger; Christopher Chan; Ravi I Thadhani; S Ananth Karumanchi; Anders H Berg
Journal:  Hemodial Int       Date:  2016-06-21       Impact factor: 1.812

Review 4.  Bone marrow cell therapies for endothelial repair and their relevance to kidney disease.

Authors:  Darren A Yuen; Richard E Gilbert; Philip A Marsden
Journal:  Semin Nephrol       Date:  2012-03       Impact factor: 5.299

5.  Bridging the gap: a Canadian perspective on translational kidney research.

Authors:  Amber O Molnar; Darren A Yuen; Navdeep Tangri; Victor L Jensen
Journal:  Can J Kidney Health Dis       Date:  2014-08-29

Review 6.  How do Uremic Toxins Affect the Endothelium?

Authors:  Regiane Stafim da Cunha; Andressa Flores Santos; Fellype Carvalho Barreto; Andréa Emilia Marques Stinghen
Journal:  Toxins (Basel)       Date:  2020-06-20       Impact factor: 4.546

7.  Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study.

Authors:  James R Lineen; Michael Kuliszewski; Niki Dacouris; Christine Liao; Dmitriy Rudenko; Djeven P Deva; Marc Goldstein; Howard Leong-Poi; Ron Wald; Andrew T Yan; Darren A Yuen
Journal:  Can J Kidney Health Dis       Date:  2015-07-30

8.  Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients.

Authors:  Chien-Lin Lu; Jyh-Gang Leu; Wen-Chih Liu; Cai-Mei Zheng; Yuh-Feng Lin; Jia-Fwu Shyu; Chia-Chao Wu; Kuo-Cheng Lu
Journal:  Int J Med Sci       Date:  2016-02-20       Impact factor: 3.738

9.  Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.

Authors:  Darren A Yuen; David M Kepecs; Yanling Zhang; Suzanne Advani; Kerri Thai; Kim A Connelly; Richard E Gilbert
Journal:  Can J Kidney Health Dis       Date:  2015-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.